Drug intelligence / Profile preview

morinda officinalis oligosaccharide

Development stage
Phase 4
Lead developer
Beijing Union University
Modality
Small Molecules
Administration
Oral
01

Overview

Morinda officinalis oligosaccharide is a bioactive compound extracted from the roots of the traditional Chinese medicinal plant Morinda officinalis. It is an oral drug approved in China for the treatment of depression. The primary mechanism involves modulation of neurotransmitter systems and anti-inflammatory pathways, including increasing brain-derived neurotrophic factor (BDNF) expression, reversing monoamine neurotransmitter imbalance, and modulating gut microbiota composition. It also acts on the tryptophan–5-hydroxytryptophan (5-HTP)–serotonin metabolic pathway in the gut microbiota by increasing tryptophan hydroxylase levels and inhibiting 5-hydroxytryptophan decarboxylase activity, leading to increased 5-HTP absorption and improved serotonin levels in the brain. Additional mechanisms include suppression of hippocampal inflammation via E2F2-mediated MyD88/PI3K signaling pathways. Besides its antidepressant effects, it has shown potential benefits for sexual dysfunction associated with depression[2][3][5][6].

Brand names
Morinda officinalis oligosaccharide capsule
Other names
Morinda officinalis oligosaccharidesMorindae officinalis radix oligosaccharides
02

Targets

DDC (Aromatic L-amino acid decarboxylase)NTRK2 (Tropomyosin-related kinase receptor type B)E2F transcription factor 2–MyD88 promoter DNA interactionTPH1 (Tryptophan 5-hydroxylase 1)E2F2 (E2F transcription factor 2)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on morinda officinalis oligosaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morinda officinalis oligosaccharide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call